Avsnitt
-
Jessie welcomes Dr. Harold Han, President, and Chief Science Officer of Vertosa, to share his insight into the world of cannabis formulations. Dr. Harold shares his transition from seven years at Bio-Rad to co-founder of Vertosa and becoming a cannabis advocate, and they discuss the remarkable progress made in the last decade. Dr. Harold discusses the innovation in formulating familiar cannabis products like beverages, edibles, and gummies. At the end of the episode, Dr. Harold and Jessie look into the potential of cannabis-infused beverages and the future of formulations in the next decade and highlight the potential for exciting innovations.
**The information, opinions, and views expressed in this podcast are those of Mr. Kater and his guests only and may not reflect the views of Curaleaf or its employees. The material and information presented here is for general information purposes only. Curaleaf does not endorse or recommend any particular product or service discussed, including products containing cannabinoids. Products discussed in this podcast may not be available to all listeners depending upon the residence state of the listener, the listener’s age, etc. Any products discussed in this podcast are not intended to diagnose, treat, cure, or prevent any disease.
Topics of Discussion:
[1:47] Harold talks about his time at Bio-Rad and how he made his way to co-founding Vertosa.
[2:24] Vertosa’s main focus is the beverage sector.
[2:50] More about Vertosa’s products and customers.
[4:34] What were some problems with the original state of edibles and their formulation technologies?
[8:11] What are we doing to cannabis to make it water soluble and to make the onset faster?
[12:14] Harold walks us through why the bioavailability is much higher with the use of emulsions.
[14:04] The difference between a nano emulsified cannabinoid vs. a traditionally consumed cannabinoid.
[18:53] The spider web concept of the four segments: the flavors, stability, manufacturability and effect.
[22:47] Different technologies will be used depending on the type of formulation. For example, a tincture, beverage, etc.
[25:36] wWhat are pharmacokinetics and pharmacodynamics?
[36:41] Cannabis bitterness and flavor enhancement.
[45:23] What type of things may be possible in the next 5 years? Innovation vs. regulation.
[50:07] Harold’s go right now - adding emulsion into his cup of tea. Also makes a great party drink!
Want to Learn More?
Cannabis Unraveled: Instagram
Vertosa
Dr. Harold Han
Quotes:
“I think the goal is to make the whole experience enjoyable and repeatable, and to be consistent.” [5:10] Harold “It’s an interesting comparison between alcohol beverages and cannabis beverages to say the least.” [16:32] Harold “I hope using this spiderweb concept can help a company like Vertosa to have a deeper understanding of how innovation will change the way it tastes for our ingredients.” [19:29] Harold -
Host Jessie Kater welcomes Alex Kwon, Co-Founder and CEO of Advanced Vapor Devices (AVD). Together, they discuss the ever expanding and developing world of cannabis vapor hardware. Alex talks about the journey that led AVD from a concept to a company working alongside hundreds of major brands in the cannabis space. Alex touches on AVD's dedication to staying on the cutting edge of innovation and how their approach to cannabis hardware stands out.
During their conversation, they go deeper into the significance of the plant and the importance of understanding the nuances of cannabis extracts. This comprehensive knowledge of the supply chain shapes the way AVD has been able to deliver hardware that enhances the cannabis experience with a primary focus on reliability and trust. At the end of the episode, Alex and Jessie share some of their favorite products.
**The information, opinions, and views expressed in this podcast are those of Mr. Kater and his guests only and may not reflect the views of Curaleaf or its employees. The material and information presented here is for general information purposes only. Curaleaf does not endorse or recommend any particular product or service discussed, including products containing cannabinoids. Products discussed in this podcast may not be available to all listeners depending upon the residence state of the listener, the listener’s age, etc. Any products discussed in this podcast are not intended to diagnose, treat, cure, or prevent any disease.
Topics of Discussion:
[1:55] Alex’s history and how he formed AVD.
[7:15] Alex’s interest in cannabis.
[8:20] The plant chooses its stewards.
[12:18] A student and the teacher.
[13:50] Some of the things Alex saw in the supply chain.
[17:03] The key components of a vape cart and the differences between cannabis and nicotine hardware.
[22:37] How hardware evolved to meet the needs of a wide range of oils.
[34:39] Ceramic core vs. traditional wick heating systems.
[40:26] Building a team and expanding partners.
[43:28] What does sustainability and green initiatives mean to AVD?
[47:52] The future of vape hardware.
[49:47] Favorite products; Select Briq.
Want to Learn More?
Cannabis Unraveled: Instagram
AVD
Alex Kwon | LinkedIn
Quotes:
“One thing led to another, and it got bigger and bigger, and it just took off like a rocketship. But it was really informed by our knowledge of understanding what’s going on with the plants and obviously working with the hardware.” - [6:33] Alex“It always comes back to reliability for the client.” - [25:12] Alex“We’re there to serve the client more than anything, and add value in that regard so they trust that.” [27:12] Alex “It doesn’t mean that we’re not looking at everything and developing our own way to disrupt what we think is the standard norm today. But until we find that and substantiate it, protect it, and then obviously, eventually commercialize it, which is a whole different animal, it’s an important part to understand where we are in this stage and age of the industry.” [36:36] Alex “It’s how you marry those types of things: running a business, providing value to your clients, and being conscious of the earth and the next stages that need to happen. But again, that’s not going to happen overnight.” [46:56] Alex “At the end of the day, our customers and clients know that we as a partner are going to be not only innovating, but we’re going to make sure that those things are reliable and trustworthy for them.” [49:22] Alex -
Saknas det avsnitt?
-
In this episode, we shine a spotlight on the fascinating world of cannabis genetics. We’re joined by expert guests Ralph Risch, CEO of Phylos, and Jared Reynbery, Senior Director of Breeding of Phylos, a company with a rich history in cannabis genetics. Additionally, we’re joined by Dr. Matthew Indest, Technical Director of Agronomy and Plant Improvement at Curaleaf.
In this conversation, we'll explore how Phylos found their footing in the cannabis industry, and gain insights into the evolution of cannabis genetics. We will also discuss the elements and tools that are integral to a successful breeding pipeline, and the exciting technological developments that are currently underway.
**The information, opinions, and views expressed in this podcast are those of Mr. Kater and his guests only and may not reflect the views of Curaleaf or its employees. The material and information presented here is for general information purposes only. Curaleaf does not endorse or recommend any particular product or service discussed, including products containing cannabinoids. Products discussed in this podcast may not be available to all listeners depending upon the residence state of the listener, the listener’s age, etc. Any products discussed in this podcast are not intended to diagnose, treat, cure, or prevent any disease.
Topics of Discussion:
[1:08] Phylos’ start in 2014 as one of the first science companies in the cannabis industry.
[1:53] What is the “Phylos Galaxy”?
[3:38] How Phylos built a tool set that would enable them to rapidly breed.
[5:14] F1 Hybrid Seeds.
[7:04] What is a genetic marker?
[9:17] How cannabis compares to finding genetic markers compared to other industries?
[10:53] Are we able to establish the actual authenticity of a strain or genetics through these biomarkers? Example: Sour Diesel from dispensaries on the West Coast.
[14:43] While the genetic distinction between indica and sativa is unclear, the terms are still useful for describing how the plant grows or affects consumption.
[17:04] Are consumers making the right choice when they're just buying Indica and Sativa, or is there a better way to approach this?
[17:01] A lot of previously held assumptions aren’t true, and this is why Phylos is excited for this Cannabis 3.0 effects based approach.
[19:19] The tools and approaches used to have cannabis strains producing higher concentrations of a highly beneficial cannabinoid.
[21:02] The use of markers to accelerate the breeding.
[24:32] Breeding with intent.
[29:02] Have we reached or approached the upper limit of the potency we physiologically put onto the plant?
[32:15] The approach towards bringing out the incredible and diverse flavors and tastes that cannabis can now produce, including a…cheddar cheese / mango hybrid?
[43:07] What is Hop Latent Viroid (HLVd), and how do you test for it and potentially mitigate against it?
[49:05] The group shares their predictions on the big breakthroughs of cannabis and where we may be from a technological standpoint 10 years from now.
Want to Learn More?
Cannabis Unraveled: Instagram
Phylos
Ralph Risch | LinkedIn
Jared Reynbery | LinkedIn
Matthew Indest | LinkedIn
Dr. Selina Wang, UC Davis
Quotes:
“Phylos was designed to really bring the cannabis plant into the modern era, and bring those traits to cannabis and also create F1 hybrid seeds lines, which are something we think ultimately enable the lowest cost production.” – Ralph [3:00]“The key next step for us was not just genotyping the plants, but phenotyping them. So gathering data on all of the interesting traits and then marrying up that data with the genotype data.” – Ralph [12:08]“The more that we have worked with the rare cannabinoids and not just on the cultivation, but now extraction, post processing, formulation and efficacy testing, the more we realized that a lot of the previously held assumptions are just not true.” – Ralph [17:01]“I think we're now in a place where you can do the science, the research, you can have subjects consuming, and you can find out what effects they're really feeling. So, it should be a lot less subjective than it used to be.” – Ralph [18:01] -
In this episode, we focus on the latest developments in the world of medicinal cannabis, including the recent recommendation by the Department of Health and Human Services to reclassify cannabis as a schedule three compound. Joining us is Dr. Scott Halpern, the distinguished John M. Eisenberg Professor of Medicine, Epidemiology, and Medical Ethics and Health Policy at the University of Pennsylvania, and the founding director of the Palliative and Advanced Illness Research (PAIR) Center. Dr. Halpern and host Jessie Kater explore the potential benefits of medical cannabis in palliative care, emphasizing the critical need for an evidence-based approach to guide its usage in symptom management and patient care. They also discuss the pivotal role of academic institutions and medical professionals in shaping the future of cannabis research, underscoring the importance of rigorous scientific investigation.
**The information, opinions, and views expressed in this podcast are those of Mr. Kater and his guests only and may not reflect the views of Curaleaf or its employees. The material and information presented here is for general information purposes only. Curaleaf does not endorse or recommend any particular product or service discussed, including products containing cannabinoids. Products discussed in this podcast may not be available to all listeners depending upon the residence state of the listener, the listener’s age, etc. Any products discussed in this podcast are not intended to diagnose, treat, cure, or prevent any disease.
Topics of Discussion:
[3:29] How Scott got interested in palliative care.
[4:44] Jessie discusses going to North Carolina to educate members of the North Caroline House on cannabis.
[8:35] More about the study on the benefits of medical cannabis in which Scott is a principal investigator.
[13:32] How natural remedies compare and fit in with pharmaceuticals.
[18:15] The challenge of reconciling widespread real-world anecdotes about cannabis's therapeutic benefits with the scientific rigor required to establish its safety and efficacy.
[23:41] Two approaches to measuring cannabis use in the real world.
[31:08] Prescription based cannabinoids.
[35:07] The future of the industry partnering with medical professionals to do the scientific and clinical work to bring in that higher level of evidence.
[35:34] The need for clarity and transparency of medical professionals when advising their patients to use cannabis.
Want to Learn More?
Cannabis Unraveled: Instagram
Dr. Scott Halpern
Quotes:
“It’s very clear to me that medical cannabis is increasingly a commonly used and often clinician recommended piece of the palliative care puzzle.” - [7:23] - Scott“My role in this really is to elevate the quality of the science around medical cannabis, so that patients, family members and clinicians can make more informed decisions.” - [8:29] - Scott -
In this episode, our focus converges on the cornerstone of cannabis testing and the indispensable role of testing labs. Joining host Jessie in this conversation is Rafael Bombonato, Executive Vice President of Quality Assurance at ACT Laboratories and Dr. Bob Miller, Chief Scientific Officer at ACT Laboratories. They first discuss the mission of testing labs in the cannabis industry, the challenges inherent in their operations, and the unyielding commitment to ethics and transparency that elevates the industry's standards. Then, the conversation flows into the danger of illicit market products, state auditing models, and the Trust In Testing program, making it more affordable and manageable for high quality testing that provides consistent and reliable results.
**The information, opinions, and views expressed in this podcast are those of Mr. Kater and his guests only and may not reflect the views of Curaleaf or its employees. The material and information presented here is for general information purposes only. Curaleaf does not endorse or recommend any particular product or service discussed, including products containing cannabinoids. Products discussed in this podcast may not be available to all listeners depending upon the residence state of the listener, the listener’s age, etc. Any products discussed in this podcast are not intended to diagnose, treat, cure, or prevent any disease.
Topics of Discussion:
[2:29] The general purpose of testing labs in the cannabis industry.
[4:16] Some of the different categories that are tested in consumer safety testing.
[5:04] Differences between state-level and federally regulated testing.
[6:02] Efforts to harmonize and bring best practices across the industry.
[9:53] Does lab testing guarantee that consumers won't have risks associated with their cannabis?
[12:00] The danger of illicit market products.
[13:38] What’s happening in the hemp space from a testing perspective.
[18:26] The intersection of consumer safety and business.
[26:11] The challenges of running a testing lab, dealing with competition, and how they face those pressures.
[29:07] The Trust In Testing Program and how it’s working to raise the standards as a group for all laboratories.
[31:30] How state auditing works and examples where it's already being done.
[33:17] The round robin testing in Michigan where the sample comes in blind.
[35:06] How the test market is evolving.
[41:12] Advice for consumers when it comes to product safety.
Want to Learn More?
Cannabis Unraveled: Instagram
Rafael Bombonato and Dr. Bob Miller: ACT Laboratories
Trust In Testing
Quotes:
“What we like to say at ACT Labs is what is on the label is in the bottle, so we take this quite seriously.” - Bob 2:25“There are definitely those conversations that are beginning to occur, particularly with regulators. But, I think we’re probably a good bit away from being able to get such standards established.” - Bob 6:37“You’re always in this race of trying to stay ahead and to try to look at all the potential opportunities, and there’s always other materials that are showing up that we haven’t been able to identify because we are lacking a standard. So, it’s always a race trying to catch up.” - Bob 16:31“Part of our responsibility is to provide legally defensible results. So, we have to provide an accurate result, which in my opinion would be a disservice to our customer.” - Rafael 26:11“Hopefully at the end of the day, we always tell our folks that the good guys and girls will eventually win.” - Bob 30:57“It may take a long time, but the people that are above board that are ethical will eventually win. We think this will actually jumpstart this to an even greater place.” - Bob 31:05 -
In this episode, host Jessie Kater explores the rapidly evolving hemp industry, with a wide range of products being marketed and sold through regulated channels. Jessie welcomes two industry insider guests to shed light on this topic; David Neundorfer, Co-founder & CEO of Open Book Extracts, offers invaluable insights into responsible hemp-derived cannabinoid production. Morgan Davis, a renowned cannabis attorney, provides expertise on the legal aspects of the hemp-derived space and shares advice for consumers navigating this diverse market. The crew discusses the industry's trajectory, regulatory challenges, and hopes for the future, including the upcoming 2023 Farm Bill. They also cover the challenges of obtaining a level playing field in the industry, potential market course corrections, and tips for navigating this ever-changing landscape.
**The information, opinions, and views expressed in this podcast are those of Mr. Kater and his guests only and may not reflect the views of Curaleaf or its employees. The material and information presented here is for general information purposes only. Curaleaf does not endorse or recommend any particular product or service discussed, including products containing cannabinoids. Products discussed in this podcast may not be available to all listeners depending upon the residence state of the listener, the listener’s age, etc. Any products discussed in this podcast are not intended to diagnose, treat, cure, or prevent any disease.
Topics of Discussion:
[2:04] David shares his journey of transitioning from automotive manufacturing and industrial automation to the cannabis space in 2017.
[3:03] Open Book Extracts' mission is to be a responsible, trusted, transparent, one-stop shop for ingredients, formulation, research and development, and finished goods manufacturing.
[5:40] Morgan discusses her pathway to cannabis and highlights the fine line between civil and criminal liability in the cannabis space.
[6:09] How Morgan became a leading expert on the legal and regulatory aspects, evolving to the emerging hemp psychoactive market.
[8:43] David and Morgan offer their perspectives on the evolution of the cannabis market and the journey from the 2018 Farm Bill to its current state.
[11:24] How the cannabis industry has outpaced the law and the challenges this presents.
[19:39] Recommendations for manufacturers seeking entrepreneurial opportunities and advice for consumers navigating the hemp market.
[20:09] Why consumers must advocate for themselves, especially in emerging markets with ambiguous regulations.
[32:44] The group discusses whether the current state of the cannabis industry benefits the overall market.
[35:31] David shares his hope for the 2023 Farm Bill, emphasizing the importance of a harm reduction approach and the role of market forces.
[37:06] Creating a safe harbor with specific requirements to attract large retailers and support responsible brands.
[42:18] Morgan shares insights on North Carolina's proposed HB 563 and its potential implications.
[44:53] The significance of comprehending the risks and opportunities in the cannabis market.
[56:25] The group emphasizes the importance of always checking the ingredient panel in hemp-derived products.
[58:22] Opportunities and hope for the 2023 Farm Bill.
[58:55] David advocates for setting a level playing field in the market, allowing for growth and encouraging investment in safety studies for more transparent sharing of results.
Want to Learn More?
Cannabis Unraveled: Instagram
Morgan: Website
David: Open Book Extracts
Quotes:
“There's this connection between the criminal world and the hemp world. It's a very slippery slope from civil to criminal liability in this space, even now. - [3:42] Morgan“The law is always way behind where any industry is. The law is very reactive. It's not proactive. - [11:24] - Morgan“If you’re a legal geek like me, it’s fascinating to watch the slight tweaks that happen on a state-by-state basis, causing this incredible innovation to happen where you see people in R&D constantly pushing the envelope of what they can make within the given guidelines.” [12:14] - Morgan“This plant is so versatile. And now, we’ve opened the door to be able to actually spend some time with it. Up until recently, you couldn’t do anything with it. You couldn’t experiment with it, and there was no legal pathway. Now, almost anybody can.” [13:42] - Morgan“Consumers, always have to advocate for themselves and be their own kind of citizen doctor, especially in emerging markets where regulations haven’t been clarified.” - [18:50] - David“It's also an unlevel playing field for low-THC brands that are legitimately focused on health and wellness products. And I think it's led to a point right now where something's gotta give.” - [34:43] - David“So rather than putting the onus on the FDA and Congress, create some level playing field across manufacturing standards, labeling requirements, and age verification where necessary. That allows the market to really open up, but open up for the groups that are putting these products through the paces that they deserve to ensure consumer health and safety.” [37:46] - David“I'm actually a big supporter of more broad access to cannabis. I think that everyone should have responsible access, whether under adult use or therapeutic applications.” [38:09] - Jessie“Always look for an ingredient panel. You need to know what is in that product, and if it does not list the ingredients, do not buy it.” - [56:25] Morgan -
It’s all about extraction this week as host Jessie welcomes two experts, Jason Laronde, Head of Sales at Vitalis, a leading CO2 equipment manufacturer, and Kyler Buck, Co-Founder of Luna Technologies, a prominent player in the hydrocarbon space. Together, they dive into the fascinating evolution of extraction technologies and techniques, shedding light on the substantial investments their companies have made in engineering and science to enhance these technologies. Not only have these advancements bolstered the quality and efficiency of the products available on the marketplace today, but they have also greatly expanded the options available to consumers.
**The information, opinions, and views expressed in this podcast are those of Mr. Kater and his guests only and may not reflect the views of Curaleaf or its employees. The material and information presented here is for general information purposes only. Curaleaf does not endorse or recommend any particular product or service discussed, including products containing cannabinoids. Products discussed in this podcast may not be available to all listeners depending upon the residence state of the listener, the listener’s age, etc. Any products discussed in this podcast are not intended to diagnose, treat, cure, or prevent any disease.
Topics of Discussion:
[2:00] Jason and Kyler introduce themselves and go into a little detail on how they got into the cannabis industry.
[6:00] In Curaleaf’s growth over the last 6 years, they have seen a little bit of all of the big techniques. These include CO2, hydrocarbon extraction, ethanol extraction, solventless extraction through hash and rosin, and then even some novel technology.
[6:55] The pros and cons of CO2 from a manufacturing and consumer perspective.
[15:23] The primary reason people use ethanol.
[19:20] Jason and Kyler share a broader perspective on the strengths and weaknesses of the primary extraction techniques used in the industry today.
[19:53] At the end of the day, it does come down to the customer.
[20:26] More about the subcritical process at Vitalis, using a sub zero liquid CO2 as a solvent.
[24:17] Kyler agrees there is a chance for multiple techniques and it’s not necessarily one size fits all approach.
[30:12] The best things to come out of regulation and legalization, include consumer safety and testing.
[34:19] The biggest evolution may be the ability to use ethanol extraction at very low temperatures.
[36:02] How has CO2 extraction evolved since earlier days?
[43:03] The evolution of hydrocarbon has probably been one of the most drastic advancements.
[46:19] How CO2 has evolved to make a more flavorful extract product.
[50:57] Technology innovation in the cannabis industry.
[56:12] Jasn and Kyler share what products they are personally enjoying.
Want to Learn More?
Cannabis Unraveled: Instagram
Vitalis
Luna Technologies
Quotes:
“The first time I saw a vape cartridge on the shelf, I really realized at that moment that extraction and the convenience of vaping was the future.” - Kyler [3:22]“With this equipment that has been engineered and manufactured for the process, not only is it safe, but you could get down to zero parts per million residential solvents and end up with a very high-quality scalable process.” - Kyler [13:42]“It all boils down to one common theme, and that’s the consumer. At the end of the day, if the customer doesn't like it and doesn't want to buy it, then it's not a successful product.” - Jason [19:26]“It's a really interesting and exciting time in the industry where technology is.” - Jason [22:55]“The benefits of legalization, having a highly regulated and highly tested market ensures a safe product to the consumer.” [31:31] Kyler“It's okay if you make a product. But can you make products economically at scale? And can you make a product that consumers want to buy repeatedly? “ [51:20] - Jason -
Welcome to the first episode of Cannabis Unraveled, where we delve into the fascinating intersection of cannabis and science, featuring host, Jessie Kater, a 20-year veteran of R&D in defense, pharmaceutical, and cannabis industries, and the SVP of Innovation and R&D at Curaleaf.
In this episode, Jessie engages in an insightful conversation with Dr. Shawna Vreeke, the Head of Research at True Terpenes. As a strong advocate for the responsible use of cannabis, Shawna has some great insights on the intricacies and potential benefits of the entourage effect, shedding light on how specific flavors, compounds, and therapeutic effects are revolutionizing the evolving cannabis market.
While the industry continues to evolve, Jessie and Shawna highlight the need for further research to fully comprehend the complex relationships between cannabinoids, terpenes, and the endocannabinoid system, aiming to optimize therapeutic applications.
**The information, opinions, and views expressed in this podcast are those of Mr. Kater and his guests only and may not reflect the views of Curaleaf or its employees. The material and information presented here is for general information purposes only. Curaleaf does not endorse or recommend any particular product or service discussed, including products containing cannabinoids. Products discussed in this podcast may not be available to all listeners depending upon the residence state of the listener, the listener’s age, etc. Any products discussed in this podcast are not intended to diagnose, treat, cure, or prevent any disease.
Topics of Discussion:
[1:50] Dr. Shawna’s background in the cannabis industry and focus on toxicology research.
[7:22] What is the entourage effect?
[13:46] Terpenes and their ability to be bioactive.
[16:28] How do you find the right cannabis products or blends for you?
[22:24] Dr. Shawna’s frustration when people refer to True Terpenes as “fake terpenes”.
[23:18] The evolution of botanical terpenes in the cannabis industry.
[24:21] Europe and other countries in the world are really focusing on cannabis for medical benefits.
[29:21] A pharmaceutical application that's now approved as a single cannabinoid based treatment for the treatment of childhood epilepsy.
[32:00] Why are we seeing consumer adverse effects, and what can we learn from this?
[34:37] A higher potency doesn’t always mean a better experience.
[36:10] Does Curaleaf notice an evolution in consumers as a state’s cannabis laws change over time?
[38:21] Marketing is so far ahead of the science in this realm, that a lot of what people find is through trial and error.
[40:01] Combination of botanical and hemp terpenes in vape pens.
[43:01] The evolution of hemp-derived terpenes.
[46:02] The need to collaborate as an industry.
47:02] Why rosin is a premium product right now.
Want to Learn More?
Cannabis Unraveled: Instagram
True Terpenes: Website
Dr. Shawna Vreeke: LinkedIn
Quotes:
"I think as consumers get more educated, as they get used to the cannabis space and play around with more products, they find that certain smells or certain terpene profiles give them the effect that they desire." [12:04] Shawna"The best thing that a consumer can do is really use their nose. What smells good to you is probably what your body is going to desire." [13:05] Shawna"As an employee of True Terpenes, we put a lot of passion and love into our terpene products." [22:05] Shawna"I think the complexity becomes how are people using these products, what real science is happening to give people more reason or evidence or better formulations for true therapeutic applications." - Jessie [27:30]"I've been consuming for approaching 30 years now, and what I've learned is to start to balance my intake." - Jessie [33:58]“I think consumers are finding that it's way more than just about total THC. It's about the experience, which we know is really dictated by these other constituents that are present in that product.” - Jessie [36:39]“We need to collaborate as an industry, right? All these different facets of scientists in the cannabis industry, we also make up the entourage effect of the industry.” - Shawna [45:44]"Give me my live rosin. Add some flavor terps on top of it. Unstoppable." - Shawna [49:55]"If regulators have learned anything, it's that all-in or all-no doesn't just work." - Jesse [51:33]"Trust yourself, trust your body." - Shawna [55:55] -
Cannabis Unraveled provides an inside look into the most relevant topics at the intersection of cannabis and science. Join host Jessie Kater, 20-year veteran of R&D across defense, pharmaceutical and cannabis markets, and SVP of Innovation and R&D at Curaleaf, for unfiltered conversations about how cannabis has evolved from what was smoked in 80s to the $71 billion industry it is projected to become by 2030. From the latest in cannabis research to emerging extraction technologies and beyond, Cannabis Unraveled offers unique perspectives from experts across all sectors of the industry.
